EN DE
STOCK COMPARISON

Zydus Wellness vs Nestle India: Fair Value & Quality

Both stocks run through our valuation models. Here is how Zydus Wellness (ZYDUSWELL) and Nestle India (NESTLEIND) compare, as of Aug 19, 2026.

As of Aug 19, 2026, Fair Value Calculator sees Nestle India as the less overvalued of the two: Zydus Wellness trades at ₹497 versus a fair value of ₹89.56 (-82%), while Nestle India trades at ₹1,463 versus ₹362 (-75%).
Zydus Wellness
ZYDUSWELL.NSE · INR · Consumer Staples
-82%
upside to fair value
overvalued
Price₹497
Fair Value₹89.56
Quality36/100
Nestle India
NESTLEIND.NSE · INR · Consumer Staples
-75%
upside to fair value
overvalued
Price₹1,463
Fair Value₹362
Quality72/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Zydus WellnessNestle India
Valuation
80.4×P/E (TTM)78.9×
4.81×P/S (TTM)11.91×
3.27×P/B
43.7×EV/EBITDA53.1×
0.2%Dividend yield0.8%
₹1.20Dividend per share₹12.00
Profitability
5%Net margin15%
14%Operating margin23%
3%Return on equity76%
3%Return on assets23%
Growth
63%Revenue growth (YoY)23%
20.7%Avg. growth/yr (3Y)11.3%
16.2%Avg. growth/yr (5Y)11.7%
Balance & size
0.52×Debt / equity0.00×
$2BMarket cap$29B
expensiveGrowth qualityhealthy

Nestle India leads: 5 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Zydus Wellnessof which business quality 37 · market factors 65 Nestle Indiaof which business quality 73 · market factors 75
ProfitabilityMargins and returns on capital today
27
93
Quality GrowthAre margins and returns improving?
55
50
CashflowEarnings quality: real cash, not paper profit
15
75
Fin. StrengthBalance sheet, leverage, solvency risk
72
76
InvestmentDisciplined investing over empire-building
58
42
Low VolatilityCalm price path (market factor)
73
92
MomentumPrice trend over the last 3–12 months (market factor)
63
59
52W MomentumDistance to the 52-week high (market factor)
58
83
Net IssuanceBuybacks instead of dilution
0
82

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Zydus Wellness

DCF Models₹81.85
Earnings-Based₹128
Dividend Discount₹21.13
Multiples₹105
Asset-Based₹123
Economic Profit₹75.06
Growth Earnings₹174

23 of 23 models see the stock below the current price.

Nestle India

DCF Models₹451
Earnings-Based₹208
Dividend Discount₹229
Multiples₹278
Asset-Based₹17.92
Growth DCF₹402
Economic Profit₹198
Growth Earnings₹324

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Zydus Wellness
Bear ₹48.25Fair Value ₹89.56Bull ₹119
₹497 = current price (white tick)
Nestle India
Bear ₹253Fair Value ₹362Bull ₹452
₹1,463 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Zydus Wellness · Consumer Staples

Quality score36 · bottom 25%
Fair value upside-82% · bottom 25%

Nestle India · Consumer Staples

Quality score72 · Top 25%
Fair value upside-75% · bottom 25%

Bottom line

As of Aug 19, 2026, Fair Value Calculator sees Nestle India as the less overvalued of the two: Zydus Wellness trades at ₹497 versus a fair value of ₹89.56 (-82%), while Nestle India trades at ₹1,463 versus ₹362 (-75%).

Nestle India has the higher quality score (72/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.